Summary:
An investigational drug is being tested as a treatment for type 2 diabetes.
Qualified Participants Must:
• be between 21-75 years of age
• have been diagnosed with type 2 diabetes
• have been treated with a stable dose of TZD for at least 6 months or with metformin for at least 3 months prior to screening
• have an HbA1c between 7.1% and 10.0%
• have history of stable body weight
Qualified Participants May Receive:
$50 for each completed visit